Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features

Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R)
(Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features

BASKING RIDGE, N.J., Oct. 26 /PRNewswire/ -- Dey Pharma, L.P., a subsidiary of
Mylan Inc. (Nasdaq: MYL), today launched a newly designed, patient-friendly
EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector
maintains the simplicity, speed, safety and reliability of EpiPen
Auto-Injector with several new, user-friendly features, including being the
only auto-injector with needle-protection before and after use.

Dey President Carolyn Myers, Ph.D., said: "We are very pleased to be launching
Dey's highly anticipated next-generation, needle-protected EpiPen
Auto-Injector. The objective of the product's new features is to give those
who carry an epinephrine auto injector some additional peace of mind when it
comes to the risk of anaphylaxis. We also hope that those who are at risk of
anaphylaxis but currently don't carry an epinephrine auto injector will become
as prepared as possible for the risk of allergen exposure."

EpiPen Auto-Injector is the number one prescribed first-line emergency
auto-injector for potentially life-threatening allergic reactions known as
anaphylaxis. Anaphylaxis can occur when people with allergies to food, insect
stings, latex or other allergens come in contact with that allergen. Immediate
access to epinephrine is critical during the first few minutes of an
anaphylactic reaction.

"Prompt administration of epinephrine during a severe allergic reaction helps
save lives so it's important that people not only have immediate access to a
self-injected epinephrine but know how to properly use it," said Dr. Phil
Lieberman, Clinical Professor of Medicine and Pediatrics, University of
Tennessee College of Medicine. "This new EpiPen Auto-Injector offers
enhancements to make it easier for people to administer epinephrine quickly
and properly in an emergency situation."

The next-generation EpiPen Auto-Injector introduces built-in needle
protection, making EpiPen the only epinephrine auto-injector with no exposed
needle before and after use. Other benefits of the re-designed EpiPen
Auto-Injector include:

-- An ergonomically-designed, easy-to-grasp oval barrel with illustrated
instructions that allow for rapid understanding and proper use of
EpiPen
Auto-Injector. The oval shape also prevents the device from rolling
out
of reach during an emergency;
-- one-step flip-top carry case that allows for rapid, single-handed
removal;

-- bright orange colors and arrows to help quickly identify the needle
end
of the device and reduce the risk of accidental thumb puncture.

Importantly, any patient that currently carries or has recently received an
EpiPen or EpiPen Jr. Auto-Injector should continue to carry that EpiPen
Auto-Injector until their current pen is used or reaches its expiration date.
Upon renewal of their next EpiPen Auto-Injector prescription, patients will
automatically receive the next generation EpiPen Auto-Injector.

About Anaphylaxis
Anaphylaxis is a severe allergic reaction that involves a number of body
systems and can be fatal within minutes, either through swelling that shuts
off airways or through a significant drop in blood pressure. Anaphylaxis
occurs in people with allergies to certain foods, insect stings, medications,
latex or other allergens. As many as 15% of Americans - up to 12 million
people - have an allergy that may put them at risk for anaphylaxis. There are
up to 2,000 episodes of anaphylaxis per every 100,000 people in the U.S. each
year. The precise incidence of anaphylaxis is unknown because this serious,
life-threatening condition is believed to be underreported. The vast majority
of deaths from anaphylaxis occur in individuals who do not receive epinephrine
in time.

About EpiPen Auto-Injector
EpiPen and EpiPen Jr. (0.3 and 0.15 mg epinephrine) Auto-Injectors are for the
emergency treatment of severe allergic reactions (anaphylaxis) caused by
allergens, exercise, or unknown triggers; and for patients who are at
increased risk for these reactions.

EpiPen and EpiPen Jr. Auto-Injectors are designed for you to use immediately
in an emergency, to treat an allergic reaction fast and give you time to get
to a hospital or medical center. EpiPen and EpiPen Jr. Auto-Injectors are not
a substitute for emergency medical treatment.

As with any medication, EpiPen Auto-Injector has an expiration date printed
directly on the unit and shelf carton and should therefore be replaced when
the unit expires. The product should be stored at room temperature and never
refrigerated or kept where it might be exposed to extreme temperatures, such
as in the glove compartment of a car.

Dey Pharma, L.P., the distributor of EpiPen Auto-Injector, offers patient
support through free membership in the EpiPen Center for Anaphylactic Support
(CAS) Program(TM). This program provides helpful tips, resources and an
expiration reminder program. Information on how to join can be found on the
patient insert dispensed with the product and by visiting www.epipen.com.

Important Safety Information
Each EpiPen Auto-Injector contains a single dose of a medicine called
epinephrine, which you inject into your outer thigh. DO NOT INJECT
INTRAVENOUSLY. DO NOT INJECT INTO YOUR BUTTOCK, as this may not be effective
for a severe allergic reaction. In case of accidental injection, please seek
immediate medical treatment.

Epinephrine should be used with caution if you have heart disease or are
taking certain medicines that can cause heart-related (cardiac) symptoms.

Side effects may include an increase in heart rate, a stronger or irregular
heartbeat, sweating, nausea and vomiting, difficulty breathing, paleness,
dizziness, weakness or shakiness, headache, apprehension, nervousness, or
anxiety. These side effects usually go away quickly, especially if you rest.
If you have high blood pressure or an overactive thyroid, these side effects
may be more severe or longer lasting. If you have heart disease, you could
experience chest pain (angina). If you have diabetes, your blood sugar levels
may increase after use. If you have Parkinson's disease, your symptoms may
temporarily get worse.

Talk to your doctor to find out if you should be prescribed an EpiPen or
EpiPen Jr. Auto-Injector.

About Dey
Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty
pharmaceutical company focused on the development, manufacturing and marketing
of prescription drug products for the treatment of respiratory diseases,
severe allergic reactions and psychiatric disorders. The company puts patients
first and facilitates efficient, cost-effective partnerships with customers.
For more information, please visit www.dey.com.

About Mylan
Mylan Inc. ranks among the leading generic and specialty pharmaceutical
companies in the world and provides products to customers in more than 140
countries and territories. The company maintains one of the industry's
broadest and highest quality product portfolios supported by a robust product
pipeline; operates the world's third largest active pharmaceutical ingredient
manufacturer; and runs a specialty business focused on respiratory and allergy
therapies. For more information, please visit www.mylan.com.

EpiPen® is a registered trademark of Dey Pharma, L.P.
See accompanying full prescribing information (PI) or visit www.epipen.com for
full PI.

SOURCE Dey Pharma L.P.

Media, Ogilvy Public Relations Worldwide, +1-518-731-1385, for Dey Pharma
L.P.